ADR Biomedical Holdings (TSE:3750) Change In Inventory: 円0.00 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:3750 ADR Biomedical Holdings Inc TSE:3750
24 GF Score
Price 円764.00
GF Value 円39.25
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is ADR Biomedical Holdings Change In Inventory?

ADR Biomedical Holdings TSE:3750 -0.65% 24 Change In Inventory is 円0.00 Mil as of Mar. 2026. GuruFocus rates TSE:3750 with a GF Score™ of 24/100 and a GF Value™ of 円39.25 (Significantly Overvalued). The stock has 8 warning signs investors should review.

ADR Biomedical Holdings's change in inventory for the quarter that ended in Mar. 2026 was 円0.00 Mil. It means ADR Biomedical Holdings's inventory stayed the same from Dec. 2025 to Mar. 2026 .

ADR Biomedical Holdings's change in inventory for the fiscal year that ended in Mar. 2026 was 円-13.73 Mil. It means ADR Biomedical Holdings's inventory increased by 円13.73 Mil from Mar. 2025 to Mar. 2026 .

ADR Biomedical Holdings's Total Inventories for the quarter that ended in Mar. 2026 was 円66.41 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. ADR Biomedical Holdings's Days Inventory for the quarter that ended in Mar. 2026 was 811.78.

Inventory Turnover measures how fast the company turns over its inventory within a year. ADR Biomedical Holdings's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.11.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. ADR Biomedical Holdings's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 3.43.

ADR Biomedical Holdings  (TSE:3750) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

ADR Biomedical Holdings's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=59.3825/6.675*365 / 4
=811.78

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

ADR Biomedical Holdings's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=6.675 / 59.3825
=0.11

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

ADR Biomedical Holdings's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=59.3825 / 17.292
=3.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ADR Biomedical Holdings Change In Inventory Related Terms

ADR Biomedical Holdings Change In Inventory Historical Data

* Premium members only.

The historical data trend for ADR Biomedical Holdings's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ADR Biomedical Holdings Change In Inventory Chart

ADR Biomedical Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 211.93 88.65 15.21 58.43 -13.73

ADR Biomedical Holdings Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:3750
24GF Score
ADR Biomedical Holdings Inc TSE:3750
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ADR Biomedical Holdings Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of 円0.00 Mil mean?
ADR Biomedical Holdings (TSE:3750) has a Change In Inventory of 円0.00 Mil as of Mar. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for ADR Biomedical Holdings and its competitors.
Is ADR Biomedical Holdings' Change In Inventory too high?
ADR Biomedical Holdings' current Change In Inventory is 円0.00 Mil. Overall, ADR Biomedical Holdings has a GF Score™ of 24/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ADR Biomedical Holdings' Change In Inventory compare to VRTX and REGN?
ADR Biomedical Holdings' Change In Inventory of 円0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for ADR Biomedical Holdings and its competitors. ADR Biomedical Holdings's current Change In Inventory is 円0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ADR Biomedical Holdings stock overvalued right now?
Based on GuruFocus' analysis, ADR Biomedical Holdings (TSE:3750) is currently considered Significantly Overvalued. The stock's GF Value™ is 円39.25, compared to a current price of 円764.00 — trading 1846.5% above its estimated fair value. The current Change In Inventory is 円0.00 Mil. ADR Biomedical Holdings' overall GF Score™ is 24/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For ADR Biomedical Holdings (TSE:3750), the current Change In Inventory is 円0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ADR Biomedical Holdings (TSE:3750) Overvalued in 2026?

Based on GuruFocus' analysis, ADR Biomedical Holdings stock appears to be overvalued. The current stock price of 円764.00 is trading 1846.5% above its estimated GF Value™ of 円39.25. GuruFocus considers ADR Biomedical Holdings to be Significantly Overvalued.

Key valuation signals for TSE:3750:

  • Change In Inventory: 円0.00 Mil
  • GF Value™: 円39.25 vs. price of 円764.00 (1846.5% above fair value)
  • GF Score™: 24/100 with 8 warning signs

No single metric tells the full story. See the TSE:3750 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ADR Biomedical Holdings Business Description

Address 1-1-1 Otemachi, Otemachi Park Building, Chiyoda-ku, Tokyo, JPN, 100-0004
ADR120S Inc developing a new clinical approach to cell therapy to provide medical care to patients by providing medical care that responds to unmet medical needs based on its regenerative medicine. Its product pipeline includes Habeo; ECCO-50 and others.
24GF Score

Get the complete analysis for TSE:3750

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円764.00
Price
円39.25
GF Value